BDBM350542 1-(4-bromophenyl)-3-[4-ethyl- 2,5-dioxo-4-(propan-2- yl)imidazolidin-1-yl]urea::US10208071, Compound 4::US10434112, Compound 67::US10799518, Compound 67

SMILES CCC1(NC(=O)N(NC(=O)Nc2ccc(Br)cc2)C1=O)C(C)C

InChI Key InChIKey=DMYSYIXHXMXWBW-UHFFFAOYSA-N

Data  7 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 350542   

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350542(1-(4-bromophenyl)-3-[4-ethyl- 2,5-dioxo-4-(propan-...)
Affinity DataEC50:  6.70E+3nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350542(1-(4-bromophenyl)-3-[4-ethyl- 2,5-dioxo-4-(propan-...)
Affinity DataEC50:  6.70E+3nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350542(1-(4-bromophenyl)-3-[4-ethyl- 2,5-dioxo-4-(propan-...)
Affinity DataEC50:  4.30nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350542(1-(4-bromophenyl)-3-[4-ethyl- 2,5-dioxo-4-(propan-...)
Affinity DataEC50:  3.30nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350542(1-(4-bromophenyl)-3-[4-ethyl- 2,5-dioxo-4-(propan-...)
Affinity DataEC50:  6.70E+3nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350542(1-(4-bromophenyl)-3-[4-ethyl- 2,5-dioxo-4-(propan-...)
Affinity DataEC50:  4.30nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350542(1-(4-bromophenyl)-3-[4-ethyl- 2,5-dioxo-4-(propan-...)
Affinity DataEC50:  3.30nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
Go to US Patent